tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Carter Gould, 121 are a BUY (54.75%), 76 are a HOLD (34.39%), 24 are a SELL (10.86%).
Analyst Carter Gould, currently employed at BARCLAYS, carries an average stock price target met ratio of 68.04% that have a potential upside of 23.69% achieved within 212 days.
Carter Gould’s has documented 455 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GILD, Gilead Sciences at 07-Nov-2024.
Analyst best performing recommendations are on APLT (APPLIED THERAPEUTICS).
The best stock recommendation documented was for APLT (APPLIED THERAPEUTICS) at 3/21/2022. The price target of $2.5 was fulfilled within 3 days with a profit of $0.67 (36.61%) receiving and performance score of 122.04.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$191
$16.81 (9.65%)
10 days ago
(10-Dec-2024)
3/4 (75%)
$15.34 (8.73%)
764
Hold
$191
$16.81 (9.65%)
$205
10 days ago
(10-Dec-2024)
2/4 (50%)
$15.34 (8.73%)
507
Hold
$206
$31.81 (18.26%)
$153
28 days ago
(22-Nov-2024)
13/14 (92.86%)
$27.92 (15.68%)
293
Buy
$200
$25.81 (14.82%)
$190
1 months 7 days ago
(13-Nov-2024)
12/13 (92.31%)
$28.57 (16.67%)
490
Buy
$215
$40.81 (23.43%)
$226
1 months 8 days ago
(12-Nov-2024)
8/10 (80%)
$39.86 (22.76%)
293
Which stock is Carter Gould is most bullish on?
Which stock is Carter Gould is most reserved on?
What Year was the first public recommendation made by Carter Gould?
